These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1814287)

  • 1. Tumor heterogeneity and intrinsically chemoresistant subpopulations in freshly resected human malignant gliomas.
    Shapiro JR; Mehta BM; Ebrahim SA; Scheck AC; Moots PL; Fiola MR
    Basic Life Sci; 1991; 57():243-61; discussion 261-2. PubMed ID: 1814287
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of type beta transforming growth factor in combination with retinoic acid or tumor necrosis factor on proliferation of a human glioblastoma cell line and clonogenic cells from freshly resected human brain tumors.
    Helseth E; Unsgaard G; Dalen A; Vik R
    Cancer Immunol Immunother; 1988; 26(3):273-9. PubMed ID: 3164258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal tumor cell heterogeneity.
    Shapiro JR; Shapiro WR
    Prog Exp Tumor Res; 1984; 27():49-66. PubMed ID: 6385127
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro analysis of the cellular resistance to chemotherapeutic BCNU.
    Caballero Navarro A; Conde Guerri B; Sinues Porta E; Boada Apilluelo E; Alcalá Arellano A
    Histol Histopathol; 1992 Jul; 7(3):347-51. PubMed ID: 1504454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitivity testing for human brain tumors.
    Rosenblum ML
    Prog Clin Biol Res; 1980; 48():259-76. PubMed ID: 7208520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of gliomas: potential clinical implications of glioma cellular heterogeneity.
    Bigner DD
    Neurosurgery; 1981 Sep; 9(3):320-6. PubMed ID: 6272152
    [No Abstract]   [Full Text] [Related]  

  • 8. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
    J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliomagenesis: genetic alterations and mouse models.
    Holland EC
    Nat Rev Genet; 2001 Feb; 2(2):120-9. PubMed ID: 11253051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme.
    Shapiro JR; Ebrahim SA; Mohamed AN; Pu PY; Shapiro WR
    J Neurooncol; 1993 Mar; 15(3):209-27. PubMed ID: 8395568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinacrine enhances carmustine therapy of experimental rat glioma.
    Reyes S; Herrera LA; Ostrosky P; Sotelo J
    Neurosurgery; 2001 Oct; 49(4):969-73. PubMed ID: 11564260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of renal subcapsular assay to human malignant glioma--a new screening method in vivo for antitumoral drugs].
    Hamada H; Asakura T; Matsuda K; Wechsler W; Rathmer K
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1513-5. PubMed ID: 2409928
    [No Abstract]   [Full Text] [Related]  

  • 14. Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
    Kaaijk P; Troost D; de Boer OJ; Van Amstel P; Bakker PJ; Leenstra S; Bosch DA
    Br J Cancer; 1996 Jul; 74(2):187-93. PubMed ID: 8688320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of gliomas.
    Kaye AH; Laidlaw JD
    Curr Opin Neurol Neurosurg; 1992 Aug; 5(4):526-33. PubMed ID: 1515691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of the potential cancer stem-like cell marker Rex-1 improves chemotherapeutic effects in gliomas.
    Kim BS; Kang KS; Choi JI; Jung JS; Im YB; Kang SK
    Hum Gene Ther; 2011 Dec; 22(12):1551-62. PubMed ID: 21810014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.
    Skalski V; Feindel W; Panasci LC
    J Neurooncol; 1989 Jul; 7(2):189-93. PubMed ID: 2476532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of cellular adhesion and invasion in gliomas].
    Sasaki H; Yoshida K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():68-73. PubMed ID: 16201502
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
    Tonn JC; Schönmayr R; Kraemer HP
    J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapeutic treatment of gliomas increases the amount of cancer stem-like cells].
    Bleau AM; Holland EC
    Med Sci (Paris); 2009 Oct; 25(10):775-7. PubMed ID: 19849969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.